HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. – Trademark Portfolio

Entity Type: 22

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include QIXINEVICHY. The owner is based in HUIZHOU CITY.

NO. 07-1, 1ST FLOOR, BUILDING 16, LANGQIN BAY, NO.1

DONGSHENG 3RD ROAD, HUICHENG DISTRICT,

HUIZHOU CITY , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. have?

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. file in?

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD.'s most well-known trademarks?

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD.'s registered trademark portfolio includes well-known marks such as QIXINEVICHY. These are among 1 currently registered trademark in the portfolio.

What is HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD.'s trademark registration success rate?

HUIZHOU CHENLI MATERNAL AND INFANT PRODUCTS CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.